Jerusalem based Entera Bio Ltd. Announces Pricing of IPO for conducting Clinical Trials of Three Orally delivered Drugs targeting the Gastrointestinal Tract
Entera Bio Ltd. (NASDAQ:ENTX) (NASDAQ:ENTXW), a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics and is conducting clinical
Kadimastem has Upgraded its Manufacturing Site for Treatment of ALS Patients in the Clinical Trial
Kadimastem chose to upgrade the production rooms, for the treatment of ALS patients in the Phase 1 / 2a clinical trial, and adapt them to
HIL Co-Founder and CTO, Prof. Arie Zigler, is a finalist for Berthold Leibinger Innovationspreis 2018
June, 2018 – Prof. Arie Zigler, HIL’s Co-Founder and CTO, and a faculty member of the Hebrew University’s Physics Department, was announced as a finalist
Ayala Pharmaceuticals Presents Phase 1b Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting for AL101, a Pan-Notch Inhibitor, in Patients with Locally Advanced or Metastatic Solid Tumors
Positive Results Support Development Pathway of AL101 as a Targeted Therapy for Patients with Tumors That Have Activating Notch Mutations Ayala Pharmaceuticals, a clinical stage
Hebrew University Researchers to Collaborate With GRAIL on Methylation Data from Multiple Cell Types to understand How to interpret the Source of blood-based Signals
Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem, announced a strategic collaboration with GRAIL, Inc., a healthcare company whose mission is to detect
Oramed Initiates a Food Effect Study for its Oral Insulin Capsule ORMD-0801
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has initiated a
BrainsWay and Cohen Veterans Bioscience Collaborating in Biomarker Research for Post Traumatic Stress Disorder
Unique Biomarkers Sought to Enable Personalized Medicine Approach for Treatment of Post Traumatic Stress Disorder (PTSD) Brainsway Ltd.(BRIN.TA), a leader in the advanced non-invasive treatment
InnovationQuarter (NL) visits the Hebrew University BioGiv “Excubator” Infrastructure Center
June 7, 2018 – InnovationQuarter (NL) visited the @BioGiv “Excubator” Infrastructure Center of the Hebrew University at the Hitech Village on the Givat Ram Campus. The
VideoTherapy to present at the Summer Expo June 28, Cleveland, Ohio
In Spring 2018, Plug and Play Cleveland Innovation Platform began it’s first inaugural Health & Wellness accelerator program. Plug and Play evaluated hundreds of startups from across
